Popularization of knowledge about PCSK9 inhibitors
About the Project
In 2018, the Eleven Zett Productions team ran extensive media activities on popularizing knowledge and raising public awareness about modern drug therapy, which are PCSK9 inhibitors. This minimally invasive and effective treatment is often the only chance for health and life for people with familial hypercholesterolaemia with the highest cardiovascular risk. Inhibitors effectively replace the painful LDL apheresis treatment, the only available available in Poland, which for patients meant a frequent and troublesome plasma transfusion. PCSK9 therapy brings not only results analogous to the mechanical way, but also improves the patient's quality of life.